Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dronabinol for Post-surgical Pain in Total Knee Replacement
NCT04099355Phase 1Withdrawn
- Sponsor
- New York State Psychiatric Institute
- Start
- Sep 2025
- Primary completion
- Aug 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in postoperative pain comparing Dronabinol with Placebo (2 arms). Primary endpoint: Brief Pain Inventory-Short Form at 2 weeks. Planned start Sep 2025; status: withdrawn.
02
Drugs
dronabinol
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04099355.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04099355.